Berlin, Germany

Dominik N Mueller

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: The University of Texas System, Max-Delbrueck-Centrum Fuer Molekulare Medizin, Max-Delbrueck-Centrum Fuer Molekulare Medizin (Mdc). Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominik N Mueller. Retrieved from https://idiyas.com/inventor/dominik-n-mueller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dominik N Mueller: Innovator in Eicosanoid Derivatives

Introduction

Dominik N Mueller is a prominent inventor based in Berlin, Germany, known for his significant contributions in the field of medicinal chemistry with a focus on eicosanoid derivatives. With a total of four patents to his name, his work addresses critical issues associated with cardiac health and inflammation.

Latest Patents

Among his latest inventions, Dominik has developed innovative eicosanoid derivatives that offer promising solutions for modulating conditions linked to cardiac damage, particularly cardiac arrhythmias. The first patent focuses on compounds categorized as n-3 PUFA derivatives that demonstrate efficacy in mitigating heart-related ailments. Furthermore, his research into CYP-eicosanoid derivatives entails analogues of epoxymetabolites produced by cytochrome P450 (CYP) enzymes, derived from omega-3 polyunsaturated fatty acids (PUFAs). This invention emphasizes compositions that can be utilized for treating or preventing diseases associated with inflammation, hypertension, coagulation, and heart failure.

Career Highlights

Dominik has been affiliated with notable institutions, including the University of Texas System and the Max Delbrück Center for Molecular Medicine. Through his innovative work, he has expanded the understanding of how eicosanoid derivatives can impact cardiovascular health and inflammation management. His dedication to research and innovation has established him as a key player in the field.

Collaborations

Throughout his career, Dominik has collaborated with distinguished professionals such as Wolf-Hagen Schunck and Gerd Wallukat. These collaborations have enhanced the depth and breadth of his research, leading to significant advancements in the applications of his inventions.

Conclusion

Dominik N Mueller exemplifies the spirit of innovation in the medical field through his research and patents related to eicosanoid derivatives. His contributions not only advance scientific understanding but also hold the potential for practical applications in improving cardiac health and managing inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…